- Home
- SABS vs BNZI Comparison
SABS vs BNZI Comparison
Compare SABS & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- BNZI
- Stock Information
- Founded
- SABS 2014
- BNZI 2016
- Country
- SABS United States
- BNZI United States
- Employees
- SABS N/A
- BNZI N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- BNZI
- Sector
- SABS Health Care
- BNZI
- Exchange
- SABS Nasdaq
- BNZI Nasdaq
- Market Cap
- SABS 15.8M
- BNZI 16.4M
- IPO Year
- SABS N/A
- BNZI N/A
- Fundamental
- Price
- SABS $1.85
- BNZI $0.87
- Analyst Decision
- SABS Strong Buy
- BNZI Strong Buy
- Analyst Count
- SABS 6
- BNZI 1
- Target Price
- SABS $11.17
- BNZI $26.00
- AVG Volume (30 Days)
- SABS 58.6K
- BNZI 816.0K
- Earning Date
- SABS 05-27-2025
- BNZI 05-15-2025
- Dividend Yield
- SABS N/A
- BNZI N/A
- EPS Growth
- SABS N/A
- BNZI N/A
- EPS
- SABS N/A
- BNZI N/A
- Revenue
- SABS $377,835.00
- BNZI $4,527,879.00
- Revenue This Year
- SABS N/A
- BNZI $580.30
- Revenue Next Year
- SABS $50.00
- BNZI $30.78
- P/E Ratio
- SABS N/A
- BNZI N/A
- Revenue Growth
- SABS N/A
- BNZI N/A
- 52 Week Low
- SABS $1.00
- BNZI $0.74
- 52 Week High
- SABS $5.01
- BNZI $19.75
- Technical
- Relative Strength Index (RSI)
- SABS 58.32
- BNZI 37.16
- Support Level
- SABS $1.76
- BNZI $0.98
- Resistance Level
- SABS $2.15
- BNZI $1.07
- Average True Range (ATR)
- SABS 0.19
- BNZI 0.06
- MACD
- SABS 0.02
- BNZI -0.01
- Stochastic Oscillator
- SABS 51.61
- BNZI 7.11
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.